109967 ⎘
dsDNA viruses; Details; Papillomaviridae Demonstrated effect
MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#2Universal vaccine platform
#3Compositions, methods and uses for thermally stable multi-targeted antigens
#4T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES FOR TREATING MUCOSAL CARCINOMAS
#5VACCINE FORMULATION COMPRISING RECOMBINANT OVERLAPPING PEPTIDES AND NATIVE PROTEINS
#6MODIFIED HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN AND USE THEREOF
#7HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT
#8CELL CAPABLE OF ACTIVATING IMMUNE SYSTEM, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID CELL
#9Compositions, methods and uses for thermally stable multi-targeted antigens
#10TARGETED COMBINATION THERAPY
#11Universal vaccine platform
#12HPV vaccine
#13Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#14Mutant of L1 protein of human papillomavirus type 18
#15HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT
#16MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#17Therapeutic HPV16 vaccines
#18Lipid A mimics, methods of preparation, and uses thereof
#19Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
#20Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
#21Universal vaccine platform
#22Therapeutic HPV vaccine combinations
#23Compositions, methods and uses for thermally stable multi-targeted antigens
#24Mutant of L1 protein of human papillomavirus type 11
#25Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#26Therapeutic HPV16 vaccines
#27MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#28NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME
#29Sexually transmitted disease vaccines
#30POLYNUCLEOTIDES FOR TREATING ONCOGENIC VIRAL POLYPEPTIDE POSITIVE TUMORS
#31Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same
#32HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof
#33Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease
#34PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand
#35Lipid A mimics, methods of preparation, and uses thereof
#36HPV-related fusion protein and applications thereof
#37Methods of treating cervical cancer
#38Therapeutic HPV16 vaccines
#39PROTEIN-CHAPERONED T-CELL VACCINES
#40Method and composition for treating cancer or skin lesion using a vaccine
#41CELL DELIVERY SYSTEM AND METHOD
#42METHODS AND COMPOSITIONS FOR INCREASING A T-EFFECTOR CELL TO REGULATORY T CELL RATIO
#43Vaccine compositions comprising a saponin adjuvant
#44Adenoviral vector vaccine
#45Polynucleotides for treating oncogenic viral polypeptide positive tumors
#46Immunity enhancing therapeutic vaccine for HPV and related diseases
#47Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses
#48Recombinant protein bodies as immunogen-specific adjuvants
#49Method of obtaining thermostable dried vaccine formulations
#50Therapeutic HPV16 vaccines
#51Cancer and skin lesion treatment
#52Vaccines against HPV
#53Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
#54PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN
#55METHOD OF VACCINATION AGAINST HUMAN PAPILLOMAVIRUS
#56VACCINES AGAINST HPV
#57Polynucleotides for treating oncogenic viral polypeptide positive tumors
#58Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
#59Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
#60CONSTRUCT SYSTEM AND USES THEREFOR
#61Recombinant Protein Bodies as Immunogen-Specific Adjuvants
#62Vaccine compositions comprising a saponin adjuvant
#63Deletion mutants of flagellin and methods of use
#64Expression system for modulating an immune response
#65THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE
#66Vaccine Compositions Comprising a Saponin Adjuvant
#67Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
#68Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity